» Articles » PMID: 15289318

Effect of N-acetyl Cysteine on Oxidative DNA Damage and the Frequency of DNA Deletions in Atm-deficient Mice

Overview
Journal Cancer Res
Specialty Oncology
Date 2004 Aug 4
PMID 15289318
Citations 54
Authors
Affiliations
Soon will be listed here.
Abstract

Ataxia telangiectasia (AT) is a hereditary human disorder resulting in a wide variety of clinical manifestations, including progressive neurodegeneration, immunodeficiency, and high incidence of lymphoid tumors. Cells from patients with AT show genetic instability, hypersensitivity to radiation, and a continuous state of oxidative stress. Oxidative stress and genetic instability, including DNA deletions, are involved in carcinogenesis. We examined the effect of dietary supplementation with the thiol-containing antioxidant N-acetyl-l-cysteine (NAC) on levels of oxidative DNA damage and the frequency of DNA deletions in Atm-deficient (AT-mutated) mice. We confirmed that Atm-deficient mice display an increased frequency of DNA deletions (Bishop et al., Cancer Res 2000;60:395). Furthermore, we found that Atm-deficient mice have significantly increased levels of 8-OH deoxyguanosine, an indication of oxidative DNA damage. Dietary supplementation with NAC significantly reduced 8-OH deoxyguanosine level and the frequency of DNA deletions in Atm-deficient mice. These levels were similar to the levels in wild-type mice. Our findings demonstrate that NAC counteracts genetic instability and suggest that genetic instability may be a consequence of oxidative stress in Atm-deficient mice.

Citing Articles

Pioglitazone as a Possible Treatment for .

Shackelford R Biomolecules. 2024; 14(10).

PMID: 39456197 PMC: 11506080. DOI: 10.3390/biom14101264.


Niosomes loading N-acetyl-L-cysteine for cancer treatment in vivo study.

Mohamad E, Ali A, Sharaky M, El-Gebaly R Naunyn Schmiedebergs Arch Pharmacol. 2023; 397(6):4339-4353.

PMID: 38091079 DOI: 10.1007/s00210-023-02893-9.


Effects of N-acetylcysteine on aging cell and obesity complications in obese adults: a randomized, double-blind clinical trial.

Sohouli M, Eslamian G, Malekpour Alamdari N, Abbasi M, Fazeli Taherian S, Behtaj D Front Nutr. 2023; 10:1237869.

PMID: 37794966 PMC: 10546057. DOI: 10.3389/fnut.2023.1237869.


Ataxia-telangiectasia clinical trial landscape and the obstacles to overcome.

Kuhn K, Lederman H, McGrath-Morrow S Expert Opin Investig Drugs. 2023; 32(8):693-704.

PMID: 37622329 PMC: 10530584. DOI: 10.1080/13543784.2023.2249399.


The Impact of Oxidative Stress on Pediatrics Syndromes.

Micangeli G, Menghi M, Profeta G, Tarani F, Mariani A, Petrella C Antioxidants (Basel). 2022; 11(10).

PMID: 36290706 PMC: 9598789. DOI: 10.3390/antiox11101983.